Thymalin represents the traditional approach to thymic peptide therapy — a complex of bioactive peptides extracted from thymus tissue that restore and normalize immune function, particularly T-cell mediated immunity.
Research Applications
Immune restoration, age-related immune decline, post-surgical recovery, chronic infection support, and T-cell function normalization.
Dosage Information (Research Use)
Clinical protocols: 5-10 mg intramuscularly daily for 5-10 day courses, repeated 1-4 times annually. Research use only.
Reconstitution & Handling
Reconstitute with provided saline or BAC water.
Half-Life & Pharmacokinetics
Variable — polypeptide complex with multiple active components.
Reported Observations in Literature
Generally well-tolerated. Rare allergic reactions reported (biological extract). Injection site soreness.
Key Research References
- Khavinson VK, Morozov VG. “Peptides of pineal gland and thymus prolong human life.” Neuro Endocrinol Lett. 2003